Reproductive Choice: Screening Policy and Acess to the Means of Reproduction

2006 ◽  
Vol 28 (2) ◽  
pp. 438-464 ◽  
Author(s):  
Lucinda Vandervort
2021 ◽  
Author(s):  
M. Jeganathan ◽  
S. Ravi Sankar ◽  
K. Karthikeyan ◽  
S. Nagarajan ◽  
G. Hariharan ◽  
...  

2019 ◽  
Vol 103 (2) ◽  
pp. 156-159 ◽  
Author(s):  
A. Tucker ◽  
R. George ◽  
W. Welfare ◽  
P. Cleary ◽  
J. Cawthorne ◽  
...  
Keyword(s):  

Author(s):  
Panagiota Nakou

Abstract An enduring ethical dispute accompanies prenatal screening and testing (PST) technologies. This ethical debate focuses on notions of reproductive choice. On one side of the dispute are those who have supported PST as a way to empower women’s reproductive choice, while on the other side are those who argue that PST, particularly when made a routine part of prenatal care, limits deliberate choice. Empirical research does not resolve this ethical debate with evidence both of women for whom PST enhances their choices but also persistent evidence of recurrent problems between PST and women’s autonomous decision-making. While there have been attempts to remove challenges to reproductive choice, it has been argued that these challenges cannot be removed entirely. In this paper I provide a historical review of PST technologies’ development and in doing so provide a detailed insight into the root causes of this tension between the opposing sides of this debate. This historical account provides evidence that those who championed the early use of these technologies did so in order to achieve a number of wholly different goals other than women’s choice and empowerment. These different aims focus on scientific discovery and eugenic goals and, I argue, are irreconcilable with women’s choice and empowerment. It thus may not be surprising that the resulting practice of PST continues to resist compatibility with women’s choice and empowerment. Ultimately, by understanding the historical foundations of PST we can more effectively assess how to reconcile women’s reproductive autonomy with routine prenatal screening.


1995 ◽  
Vol 25 (3) ◽  
pp. S21 ◽  
Author(s):  
Benjamin S. Wilfond

Author(s):  
Elizabeth Kravitz ◽  
Michelle Suh ◽  
Matthew Russell ◽  
Andres Ojeda ◽  
Judy Levison ◽  
...  

Objective: Improve racial equity with routine universal drug screening / Study Design: Commentary on the medicolegal and social history of the United States and the field of obstetrics and gynecology regarding drug screening policy / Results: Critical aspects to inform an equitable drug screening policy include (1) racial bias and stigma related to substance use, (2) the legislative history surrounding substance use during pregnancy, (3) the relationship between substance use and mass incarceration which disproportionately affects persons of color, (4) propensity toward punitive measures for Black mothers with substance use, including termination of parental rights, (5) the role of the medical field in fostering mistrust among our patients / Conclusion: new practices in screening for substance use during pregnancy are needed. Key Points


2018 ◽  
Vol 48 (5) ◽  
pp. 3-4
Author(s):  
Jonathan F. Will
Keyword(s):  

2018 ◽  
Author(s):  
Louise Livesey ◽  
Kerry Rees ◽  
Pauline Dooley ◽  
Brian Frederick ◽  
Joanna Kesy

Sign in / Sign up

Export Citation Format

Share Document